Low prognostic value of novel nocturnal oxygen saturation metrics in patients with obstructive sleep apnea and high cardiovascular event risk: Post-hoc analyses of the SAVE study
Chest Jul 17, 2020
Linz D, Loffler KA, Sanders P, et al. - By performing post-hoc analyses of the Sleep Apnea CV Endpoints (SAVE) trial, researchers investigated whether new nocturnal oxygen saturation metrics hold prognostic worth in patients with obstructive sleep apnea (OSA) and high cardiovascular (CV) event risk. The participants were 2,687 in total. The following metrics were included: oxygen desaturation index, time < 90% oxygen saturation (SpO2), average SpO2 for the whole recording (mean SpO2); average SpO2 during desaturation events (desaturation SpO2); average baseline SpO2 interpolated across episodic desaturation events (baseline SpO2); episodic desaturation event duration and desaturation/resaturation-time ratio; mean as well as standard deviation of pulse rate. Findings revealed no correlation of AHI and ODI with CV outcomes. In contrast, the pattern of oxygen desaturation was shown to be related to heart failure and myocardial infarction. However, concomitant risk factors continued to be the main determinants for secondary CV events and therefore worthy of the most intensive management.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries